Publication | Closed Access
Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study
104
Citations
35
References
2018
Year
TCZ could be a therapeutic option in patients with BD and refractory uveitis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1